TocilizumabVarious toxicities following an off-label use: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1820卷 / 1期

关键词：

D O I：

10.1007/s40278-020-83113-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：293 / 293

相关论文

共 50 条

[1] TocilizumabVarious toxicities following off-label use: 3 case reports
Reactions Weekly, 2022, 1911 (1) : 386 - 386
[2] TocilizumabVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2023, 1973 (1) : 264 - 264
[3] TocilizumabVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2020, 1803 (1) : 223 - 223
[4] TocilizumabVarious toxicities following off-label use: 4 case reports
Reactions Weekly, 2023, 1944 (1) : 529 - 529
[5] Infliximab/tocilizumabVarious toxicities following off-label use: 8 case reports
Reactions Weekly, 2023, 1948 (1) : 240 - 240
[6] TocilizumabVarious toxicities following off label use: 4 case reports
Reactions Weekly, 2021, 1856 (1) : 375 - 375
[7] DasatinibVarious toxicities following off-label use: 3 case reports
Reactions Weekly, 2021, 1881 (1) : 92 - 92
[8] PazopanibVarious toxicities following off-label use: 3 case reports
Reactions Weekly, 2023, 1939 (1) : 375 - 375
[9] RituximabVarious toxicities following an off-label use: 3 case reports
Reactions Weekly, 2018, 1683 (1) : 600 - 600
[10] BelantamabVarious toxicities following off-label use: 3 case reports
Reactions Weekly, 2023, 1961 (1) : 96 - 96

← 1 2 3 4 5 →